Repetitive phosphorus-32 peritoneal instillations in a patient with malignant ascitesBALINK, Hans; SIJMONS, Edith A; ZONNENBERG, Bernard A et al.Clinical nuclear medicine. 2003, Vol 28, Num 7, pp 545-547, issn 0363-9762, 3 p.Article

Suppression of prostate cancer induced bone remodeling by the endothelin receptor a antagonist atrasentanNELSON, Joel B; NABULSI, Azmi A; VOGELZANG, Nicholas J et al.The Journal of urology. 2003, Vol 169, Num 3, pp 1143-1149, issn 0022-5347, 7 p.Article

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trialBISSLER, John J; CHRISTOPHER KINGSWOOD, J; WHITTEMORE, Vicky H et al.Lancet (British edition). 2013, Vol 381, Num 9869, pp 817-824, issn 0140-6736, 8 p.Article

Fatty Foci in the Myocardium in Patients with Tuberous Sclerosis Complex: Common Finding at CTADRIAENSEN, Miraude E. A. P. M; SCHAEFER-PROKOP, Cornelia M; DUYNDAM, Debbie A. C et al.Radiology. 2009, Vol 253, Num 2, pp 359-363, issn 0033-8419, 5 p.Article

Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau diseaseFRANTZEN, Carlijn; KRUIZINGA, Roeliene C; VAN PAMPUS, Marielle G et al.Neurology. 2012, Vol 79, Num 8, pp 793-796, issn 0028-3878, 4 p.Article

Characterisation of TSC1 promoter deletions in tuberous sclerosis complex patientsVAN DEN OUWELAND, Ans Mw; ELFFERICH, Peter; ZONNENBERG, Bernard A et al.European journal of human genetics. 2011, Vol 19, Num 2, pp 157-163, issn 1018-4813, 7 p.Article

Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trialJAMES, Nicholas D; CATY, Armelle; PAYNE, Heather et al.BJU international (Papier). 2010, Vol 106, Num 7, pp 966-973, issn 1464-4096, 8 p.Article

Safety and Efficacy of the Specific Endothelin-A Receptor Antagonist ZD4054 in Patients with Hormone-Resistant Prostate Cancer and Bone Metastases Who Were Pain Free or Mildly Symptomatic : A Double-Blind, Placebo-Controlled, Randomised, Phase 2 TrialJAMES, Nicholas D; CATY, Armelle; BORRE, Michael et al.European urology. 2009, Vol 55, Num 5, pp 1112-1123, issn 0302-2838, 12 p.Article

Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: A randomized, phase II, placebo-controlled trialCARDUCCI, Michael A; PADLEY, Robert J; SCHMITT, Jennifer L et al.Journal of clinical oncology. 2003, Vol 21, Num 4, pp 679-689, issn 0732-183X, 11 p.Article

Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: A pharmacokinetic and long-term safety studyBEEREPOOT, Laurens V; WITTEVEEN, Els O; GROENEWEGEN, Gerard et al.Clinical cancer research. 2003, Vol 9, Num 11, pp 4025-4033, issn 1078-0432, 9 p.Article

Dihydropyrimidinase deficiency and severe 5-fluorouracil toxicityVAN KUILENBURG, André B. P; MEINSMA, Rutger; ZONNENBERG, Bernard A et al.Clinical cancer research. 2003, Vol 9, Num 12, pp 4363-4367, issn 1078-0432, 5 p.Article

A new concept for non-invasive renal tumour ablation using real-time MRI-guided radiation therapyKERKHOF, Ellen M; RAAYMAKERS, Bas W; VAN VULPEN, Marco et al.BJU international (Papier). 2011, Vol 107, Num 1, pp 63-68, issn 1464-4096, 6 p.Article

Mature fat cells in the myocardium of patients with tuberous sclerosis complexADRIAENSEN, Miraude E. A. P. M; VAN OOSTERHOUT, Matthijs F. M; FERINGA, Harm H. H et al.Journal of clinical pathology. 2011, Vol 64, Num 3, pp 244-245, issn 0021-9746, 2 p.Article

Imatinib induces hypothyroidism in patients receiving levothyroxineDE GROOT, Jan Willem B; ZONNENBERG, Bernard A; PLUKKER, John T. M et al.Clinical pharmacology and therapeutics. 2005, Vol 78, Num 4, pp 433-438, issn 0009-9236, 6 p.Article

Phase I dose-escalation study of the safety and pharmacokinetics of atrasentan: An endothelin receptor antagonist for refractory prostate cancerZONNENBERG, Bernard A; GROENEWEGEN, Gerard; JANUS, Todd J et al.Clinical cancer research. 2003, Vol 9, Num 8, pp 2965-2972, issn 1078-0432, 8 p.Article

The Placorhen study: A double-blind, placebo-controlled, randomized radionuclide study with ¹⁸⁶Re-etidronate in hormone-resistant prostate cancer patients with painful bone metastasesHAN, Shiuw H; DE KLERK, John M. H; TAN, Suzy et al.The Journal of nuclear medicine (1978). 2002, Vol 43, Num 9, pp 1150-1156, issn 0161-5505, 7 p.Article